Options
Approaches for the development of drugs for treatment of obesity and metabolic syndrome
Adipokines
Beloranib
Contrave®
Empatic™
Liraglutide
Lorcaserin
Orlistat
Pharmacotherapy of ob...
Qsymia
Rimonabant
Sibutramine
Tesofensine
Treatment of obesity ...
agents affecting meta...
amfebutamone
amfebutamone plus nal...
amfebutamone plus zon...
antiobesity agent
beloranib
exendin 4
fluoxetine
liraglutide
lorcaserin
metformin plus sitagl...
metreleptin
naltrexone
noradrenalin
pancreas enzyme
phentermine plus topi...
rimonabant
serotonin
sibutramine
tesofensine
tetrahydrolipstatin
topiramate
venlafaxine
antiobesity agent
Article
behavior therapy
body weight
cardiovascular system...
drug design
drug efficacy
drug safety
energy metabolism
human
life expectancy
lipid absorption
medical practice
metabolic syndrome X
morbid obesity
obesity
physical activity
priority journal
sleep disordered brea...
stomach secretion
weight reduction
animal
body mass
complication
drug design
drug potentiation
metabolic syndrome X
obesity
pathophysiology
risk factor
Animals
Anti-Obesity Agents
Body Mass Index
Drug Design
Drug Synergism
Humans
Metabolic Syndrome X
Obesity
Risk Factors